Diarrea clostridial. Un patógeno nosocomial a tener en cuenta / Clostridial diarrhea. A nosocomial pathogen to take into account

La diarrea clostridial es una enfermedad aguda con compromiso colónico que puede poner en riesgo la vida de un paciente. Su agente etiológico es el Clostridium difficile y se ha asociado al uso indiscriminado y por largo plazo de antibióticos de amplio espectro. Su cuadro clínico es variable, puede ir desde un cuadro de diarrea hasta la perforación colónica, que puede determinar la realización de una colectomía de urgencia o incluso provocar la muerte del enfermo. El diagnóstico de certeza se realiza mediante la detección de la toxina clostridial en materia fecal, por técnicas de inmunoensayo enzimático. La terapéutica se realiza con metronidazol o vancomicina por vía oral. El tratamiento quirúrgico está indicado ante la presencia de megacolon tóxico o perforación intestinal, y en aquellos pacientes con toxicidad sistémica con fracaso de la terapéutica médica. (AU)

Clostridial diarrhea is an acute disease with colonic involvement that can be life-threatening for a patient. Its etiologic agent is the Clostridium difficile and it has been associated with the indiscriminate and long-term use of broad-spectrum antibiotics. Its clinical picture varies from a picture of diarrhea to colonic perforation that can determine the performance of an emergency colectomy or even the death of the patient. The certainty diagnosis is carried out by detecting clostridial toxin in fecal matter by enzyme immunoassay techniques. The therapy is carried out with metronidazole or vancomycin orally. Surgical treatment is indicated in the presence of toxic mega colon, intestinal perforation or in those patients with systemic toxicity with failure of medical therapy. (AU)

Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection

Clostridium difficile is a significant nosocomial and community-acquired pathogen, and is the leading cause of antibiotic-induced diarrhea associated with high morbidity and mortality. Given that the treatment outcome depends on the severity of C. difficile infection (CDI), we aimed to establish an efficient method of assessing severity, and focused on the stool biomarker fecal calprotectin (FC). FC directly reflects the intestinal inflammation status of a patient, and can aid in interpreting the current guidelines, which requires the integration of indirect laboratory parameters. The distinction of 80 patients with CDI versus 71 healthy controls and 30 severe infection cases versus 50 mild cases was possible using FC as a marker. The area under the receiver operating characteristic curves were 0.821 and 0.746 with a sensitivity of 75% and 70% and specificity of 79% and 80%, for severe versus mild cases, respectively. We suggest FC as a predictive marker for assessing CDI severity, which is expected to improve the clinical management of CDI.

Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection

BACKGROUND/AIMS: It has been suggested that chronic kidney disease (CKD) is a risk factor for Clostridium difficile infection (CDI) and is associated with increased mortality among patients infected with C. difficile. However, recent studies of the clinical impact of CKD on CDI in Asians are still insufficient. We sought to determine the relationship between CKD and CDI in a Korean population. METHODS: This was a single-center, retrospective case-control study. In total, 171 patients with CDI were included as cases and 342 age- and gender-matched patients without CDI were used as controls. We compared the prevalence of CKD in the study sample and identified independent risk factors that could predict the development or prognosis of CDI. RESULTS: Independent risk factors for CDI included stage IV to V CKD not requiring dialysis (odds ratio [OR], 2.90) and end-stage renal disease requiring dialysis (OR, 3.34). Patients with more advanced CKD (estimated glomerular filtration rate < 30) and CDI showed higher in-hospital mortality and poorer responses to the initial metronidazole therapy. CONCLUSIONS: More advanced CKD is an independent risk factor for CDI and is associated with higher in-hospital mortality and poor treatment responses in CDI patients. Thus, in CKD patients, careful attention should be paid to the occurrence of CDI and its management to improve the outcome of CDI.

Diarrea asociada a antibióticos / Antibiotic associated diarrhea

La diarrea asociada a antibióticos es una entidad clínica que ha aumentado de manera considerable los últimos años a nivel mundial. Lo anterior se ha visto favorecido por el incremento en el uso de antibióticos de amplio espectro, los que fundamentalmente alteran la flora intestinal habitual, actuando también por otros mecanismos como la alteración de la motilidad intestinal y acción tóxica directa sobre la mucosa intestinal. La presentación clínica varía desde un cuadro leve hasta de mayor gravedad, llegando incluso a la muerte. Lo anterior dependerá de algunas variables, siendo fundamental el estado inmunitario del paciente. La diarrea asociada a antibióticos por Clostridium Difficile tiene mayor relevancia dado su mayor morbimortalidad. Se han utilizado diversos métodos diagnósticos para evaluar esta patología como así también, diferentes estrategias terapéuticas de enfrentamiento, las que se exponen en la presente revisión

Antibiotic-associated diarrhea is a clinical entity showing a significantly greater presence in past years worldwide. These has been favored by the intensification of treatments based on the use of broad-spectrum antibiotics, which alter intestinal flora and act through other mechanisms like alteration of intestinal motility and direct toxic action on the intestinal mucosa. Clinical symptoms vary from mild to severe and may even cause death. The severity of this condition depends on different variables, mainly the immune status of the patient. Clostridum difficile antibiotic-associated diarrhea is the most relevant since it causes greater mobility and mortality. This article is a review of various diagnostic methods used to evaluate this pathology and multiple therapeutical strategies for management of same.

Manipulation of a quasi-natural cell block for high-efficiency transplantation of adherent somatic cells

Recent advances have raised hope that transplantation of adherent somatic cells could provide dramatic new therapies for various diseases. However, current methods for transplanting adherent somatic cells are not efficient enough for therapeutic applications. Here, we report the development of a novel method to generate quasi-natural cell blocks for high-efficiency transplantation of adherent somatic cells. The blocks were created by providing a unique environment in which cultured cells generated their own extracellular matrix. Initially, stromal cells isolated from mice were expanded in vitro in liquid cell culture medium followed by transferring the cells into a hydrogel shell. After incubation for 1 day with mechanical agitation, the encapsulated cell mass was perforated with a thin needle and then incubated for an additional 6 days to form a quasi-natural cell block. Allograft transplantation of the cell block into C57BL/6 mice resulted in perfect adaptation of the allograft and complete integration into the tissue of the recipient. This method could be widely applied for repairing damaged cells or tissues, stem cell transplantation, ex vivo gene therapy, or plastic surgery.

Comparison of ChromID Agar and Clostridium difficile Selective Agar for Effective Isolation of C. difficile from Stool Specimens

BACKGROUND: ChromID Clostridium difficile agar (IDCd; bioMerieux SA, France) is a recently developed chromogenic medium for rapid and specific isolation of C. difficile. We compared the performance of IDCd with that of Clostridium difficile Selective Agar (CDSA). METHODS: A total of 530 fresh stool specimens were collected from patients with clinical signs compatible with C. difficile infection, and cultures for C. difficile were performed on IDCd and CDSA. C. difficile colonies were identified by spore staining, odor, use of an ANI identification test kit (bioMerieux SA), and multiplex PCR for tcdA, tcdB, and tpi. RESULTS: The concordance rate between IDCd and CDSA was 90.6% (480/530). The positivity rates on IDCd on days 1 and 2 (55.6% and 85.0%, respectively) were significantly higher than those on CDSA (19.4% and 75.6%, respectively) (P<0.001 for day 1 and P=0.02 for day 2), but the detection rates on IDCd and CDSA on day 3 were not different (89.4% vs. 82.8%, P=0.0914). On day 3, the recovery rates for non-C. difficile isolates on IDCd and CDSA were 30.2% (160/530) and 22.1% (117/530), respectively (P=0.0075). Clostridium spp. other than C. difficile were the most prevalent non-C. difficile isolates on both media. CONCLUSIONS: The culture positivity rates on IDCd and CDSA were not different on day 3 but IDCd may allow for rapid and sensitive detection of C. difficile within 2 days of cultivation.

Colitis fulminante asociada a Clostridium difficile / Fulminant colitis associated to Clostridium difficile infection

We report a 46 years old female subjected to a bilateral hip arthroplasty, who presented a diarrhea caused by Clostridium difficile. She was treated with metronidazole and vancomycin form 10 days with a good evolution. She was admitted again to the hospital three days later due to fever, malaise, diarrhea, abdominal distention and signs of hypotension. An abdominal CT scan showed images compatible with a pseudomembranous colitis. Due to the bad evolution, the patient was subjected to a total colectomy with a terminal ileostomy and closure of the rectal stump. During the postoperative period the patient was treated with parenteral nutrition, metronidazole and vancomycin. She was discharged 19 days after the operation. Fulminant colitis occurs in approximately 3 to 8 percent of patients with Clostridium difficile diarrhea and total colectomy is indicated when there is a poor response to medical treatment.

Se presenta el caso de una paciente de 46 años sometida a una artroplastía de cadera bilateral que presenta diarrea secundaria a infección por Clostridium difficile (CD), que fue tratada con metronidazol y vancomicina por 10 días con buena evolución. Reingresa 3 días después con un cuadro caracterizado por fiebre, compromiso del estado general, diarrea, distensión abdominal, deshidratación y signos de hipotensión. La tomografía computada (TC) mostró imágenes compatibles con colitis pseudomembranosa. Debido al deterioro hemodinámico a pesar del uso de drogas vasoactivas, se efectúa una colectomía total con ileostomía terminal y cierre del muñón rectal. Es apoyada con nutrición parenteral total, drogas vasoactivas y tratamiento antiobiótico específico con metronidazol y vancomicina. Luego de una tórpida evolución inicial, tiene buena evolución y se otorga el alta a los 19 días de la intervención. La Colitis Fulminante asociada a Clostridium difficile es una entidad grave que afecta al 3-8 por ciento de los casos con diarrea asociada a CD. La leucocitosis mayor de 16.000 /mm³, el uso de antibióticos en las últimas 8 semanas, la cirugía reciente (menos de 30 días) y el ácido láctico elevado eran los factores de riesgo presentes en esta paciente. La colectomía total abdominal sin anastomosis se justifica en los pacientes que no responden al tratamiento médico intensivo y/o con signos de peritonitis, 10 que ocurre aproximadamente en el 10-20 por ciento de los casos.

Colitis por Clostridium Difficile / Clostridium Difficile Colitis

La diarrea es una causa de complicación frecuente en la evolución de los pacientes hospitalizados. La gravedad al ingreso y la estadía prolongada se asocian fuertemente a la misma siendo causa de un aumento de la morbimortalidad de los pacientes afectados. El Clostridium difficile es un hallazgo común estando el mismo asociado en un alto porcentaje a aquellos pacientes que se presentan con una colitis pseudomembranosa. Durante la última década se ha asistido a un aumento en el número de casos, con un cambio en el perfil epidemiológico, presentándose como formas graves y/o mortales en pacientes sin factores de riesgo debido a la aparición de una nueva cepa con características genéticas particulares. El propósito de esta revisión es la actualización del tema en cuanto a esta nueva forma de presentación, etiopatogenia de la misma y tratamiento

Necrotizing enteritis associated with Clostridium perfringensType B in chinchillas (Chinchilla lanigera) / Enterite necrosante associado a infecção por Clostridium perfringenstipo B em chinchilas (Chinchilla lanigera)

Four 3-4 month-old chinchillas (Chinchilla lanigera) from a commercial flock of 395 chinchillas, were found dead with evidence of previous diarrhea and prolapsed rectum. A fifth 8 month-old chinchilla died 8 hours after being found recumbent, apathetic, diarrheic and with a prolapsed rectum. Two chinchillas were necropsied and observed gross lesions consisted of extensive hemorrhagic enteritis, mild pulmonary edema and enlarged and yellow liver; this latter finding was particularly prominent in the chinchilla presenting longer clinical course. Histologically there was necrotizing enteritis associated with abundant bacterial rods aggregates in the intestinal surface epithelium and within the lamina propria. In the lungs there were small amounts of pink proteinaceous material (edema) in the interstitium and marked vacuolar hepatocellullar degeneration (lipidosis) in the liver. Anaerobic cultures from the intestinal contents of one of the affected chinchillas yielded Clostridium perfringens. Genotyping of this C. perfringens isolate was achieved by multiplex polymerase chain reaction (mPCR) as C. perfringenstype B due to detection of alpha, beta and epsilon-toxin genes. These findings suggest C. perfringens type B as an important cause of sudden or acute death in chinchillas.

Quatro chinchilas (Chinchilla lanigera) com 3-4 meses de idade, pertencentes a um criadouro comercial com 395 chinchilas, foram encontradas mortas com evidências de diarreia prévia e prolapso de reto. Uma quinta chinchila, de oito meses de idade, foi encontrada em decúbito, apática, com diarreia e prolopaso de reto, e morreu após oito horas. Duas chinchilas foram submetidas à necropsia. As lesões macroscópicas consistiam de extensa enterite hemorrágica, moderado edema pulmonar e fígado pálido e aumentado de volume; este achado foi particularmente proeminente na chinchila que apresentou curso clínico mais longo. Histologicamente foi observado enterite necrosante associada a numerosos agregados bacterianos na superfície epitelial com invasão da lâmina própria. Nos pulmões foi observada pequena quantidade de material proteináceo róseo amorfo (edema) no interstício e marcada degeneração hepatocelular vacuolar (lipidose). Cultura anaeróbica do conteúdo intestinal de uma chinchila afetada revelou crescimento de Clostridium perfringens. A genotipificação de C. perfringensisolado, realizada por reação em cadeia de polymerase multiplex(mPCR), revelou C. perfringenstipo B pela detecção das tóxinas alfa, beta e épisilon. Estes achados sugerem que infecção por C. perfringenstipo B é uma importante causa de morte súbita ou aguda em chinchilas.

Comparación de métodos diagnósticos de diarreas asociadas a Clostridium difficile / Comparison of diagnostic methods for Clostridium difficile-associated diarrhea

Para comparar diferentes métodos de diagnóstico de diarreas asociadas a Clostridium difficile desarrollados en el marco de un estudio colaborativo, se analizaron filtrados de materia fecal de pacientes con sintomatología compatible con esta patología. Se evaluó la actividad biológica sobre células Vero (ensayo biológico), la reactividad frente a anticuerpos anti-TcdA y anti-TcdB (dot blot) y la presencia de secuencias del gen tcdB por PCR. De 177 muestras analizadas por el ensayo biológico, 44 tuvieron títulos mayores o iguales que 64. Diecinueve muestras fueron a la vez positivas en el ensayo biológico y en el análisis por PCR. Se analizaron 149 muestras por dot blot utilizando anticuerpos anti-TcdA y anti-TcdB; 46 muestras resultaron positivas para ambas toxinas, 12 muestras fueron positivas sólo para TcdB y 5 muestras sólo para TcdA. Las divergencias entre los diferentes métodos podrían estar relacionadas con la presencia de genes truncados, con un bajo número de microorganismos en las muestras analizadas o con la degradación de las toxinas. Los resultados presentados demuestran la necesidad de implementar alternativas diagnósticas que se adapten a la compleja realidad epidemiológica de este importante patógeno intestinal.

In order to compare different methods for the diagnosis of Clostridium difficile-associated diarrhea, fecal filtrates from patients presenting symptoms compatible with this condition, were analyzed. Biological activity on Vero cells (biological assay), dot blot with antibodies anti-TcdA and anti-TcdB, and a PCR assay for the tcdB gene, were evaluated. Titles of biological assays were ≥ 64 for 44 out of 177 samples. Nineteen samples were positive in both biological and PCR assays. The analysis by dot blot using anti-TcdA and anti-TcdB antibodies showed that 46 samples out of 149 were positive for both toxins whereas 12 samples were only positive for TcdB, and 5 samples only positive for TcdA. Discrepancies in the different methods could be related to truncated genes, low number of microorganisms in the samples and toxin degradation. The results herein presented show the need for developing diagnostic approaches compatible with the complex epidemiological situation of this clinically relevant intestinal pathogen.

A Case of Pseudomembranous Colitis in a Juvenile Rheumatoid Arthritis Patient Taking Methotrexate / 대한소화기학회지

Pseudomembranous colitis is mainly caused by antibiotics and Clostridium difficile infection. But conditions such as gastrointestinal surgery, antacid medication, anti-neoplastic agent or immunosuppressive agent which influences the normal flora of colon can induce colitis without the administration of any antibiotics. We experienced a 13 year-old male who was taking low-dose methotrexate for juvenile rheumatoid arthritis complained diarrhea and abdominal pain for 3 weeks. Sigmoidoscopic findings revealed diffuse patch yellowish pseudomembranes on the rectum. Histologic finding was compatible to pseudomembranous colitis. His symptom was improved after stop taking methotrexate and the administration of metronidazole. If a patient treated with immunosuppressive agents or antineoplastic agents complains diarrhea, fever or abdominal pain and has not improved with conservative care, pseudomembranous colitis should be taken into account as a differential diagnosis and prompt treatment is required for better prognosis.

Change of Clostridium difficile Colitis during Recent 10 Years in Korea / 대한소화기학회지

BACKGROUND/AIMS: Our clinical experience and recent published literatures suggest that Clostridium difficile colitis (CDC) has become more common and potentially more pathogenic in recent years. The aim of study was to evaluate changes in the epidemiological features of CDC in hospitalized patients in Korea. METHODS: We retrospectively reviewed all patients of CDC diagnosed at Kangnam St. Mary Hospital from 1998 to 2007. CDC was defined as having a positive C. difficile cytotoxicity assay, or endoscopic or pathologic evidence of CDC. RESULTS: A total of 189 cases (male 73, female 116, mean age 63.3 years) of CDC were diagnosed during the study period. The prevalence of CDC increased from 1.9/10,000 patient admissions in 1998-1999 to 8.82/10,000 patient admissions in 2006-2007. One hundred sixty three indication for cases (86.2%) of patients identified a prior use of antibiotics in the 2 months preceding diagnosis. The most common antibiotic use was prophylactic use during perioperational period (33.3%) followed by pneumonia (23.3%). The overall response rate to initial antibiotics was 82.7%. One hundred seventy two (91%) patients were initially treated with metronidazole. The response rate was 84.3%. All patients with initial failure to metronidazole were successfully treated by vancomycin. The response rate of vancomycin as first treatment was 80%. Three deaths were associated with CDC despite the use of combination of metronidazole and vancomycin. CONCLUSIONS: The prevalence of CDC in hospitalized patients in Korea significantly increased from 1998 to 2007.

The Incidence and Clinical Features of Clostridium difficile Infection; Single Center Study / 대한소화기학회지

BACKGROUND/AIMS: Clostridium difficile is the predominant cause of nosocomial diarrhea. Recently, the incidence of Clostridium difficile infection (CDI) increases in Europe and North America. A retrospective study was performed to evaluate the change of incidence and clinical features of CDI in Korea. METHODS: From January 2003 to December 2008, inpatients diagnosed with CDI in Seoul Paik hospital were enrolled. The diagnosis of CDI was made when patients complained diarrhea with any positive results in C. difficile toxin assay, stool culture, or endoscopy. The incidence, recurrence rate, and clinical features were compared between early period (2003-2005) and late period (2006-2008). RESULTS: The incidence of CDI was 21.73 cases per 10,000 admitted patients in early period group, and significantly increased to 71.71 cases per 10,000 admitted patients in late period group (p<0.01). The hospital stay duration at the time of CDI diagnosis was shorter in late period group. Cephalosporin had the highest ratio as the causative antibiotics of CDI. However, there was no difference in recurrence rate between early and late period groups. Recurrence associated clinical factor was serum albumin level. CONCLUSIONS: The incidence of CDI showed increasing tendency during recent 6 years. The awareness of increasing disease burden is the first step in control of CDI.

Enfermedad asociada a Clostridium difficile en América Latina / Clostridum difficile associated disease in Latin America

La enfermedad asociada a Clostridium difficile (EACD) se ha incrementado de manera sostenida en todo el mundo durante los últimos 10 años. Sin embargo, son pocos los estudios en América Latina que abordan el tema. En una revisión bibliográfica en las bases de datos documentales de los países latinoamericanos, encontramos solo siete artículos recientes en los cuales se describen las características clínicas, los factores de riesgo y, en algunos, el desenlace de la infección. De estos artículos solo uno fue prospectivo, mientras que los restantes fueron retrospectivos, transversales o de casos y controles. Esta revisión estuvo orientada fundamentalmente hacia la población adulta en hospitalización, aunque la edad de los pacientes va de los 13 años en algunos trabajos. En dos análisis recientes se realizó cultivo celular para determinar efecto citopático y en el resto la determinación fue por inmunoensayo. En todos, el empleo de antibióticos (fluoroquinolonas, clindamicina y cefalosporinas) tuvo asociación con la EACD, y el tratamiento de la enfermedad incluyó casi siempre metronidazol por vía oral; únicamente en un centro se utilizó vancomicina. La mortalidad atribuible fue menor (4%) a la informada en países desarrollados. Dado que en América Latina existen escasas investigaciones de EACD con pocos pacientes y casi todas retrospectivas, se percibió la necesidad de determinar la frecuencia de esta enfermedad, conocer mejor los factores de riesgo y las verdaderas tasas de mortalidad global y atribuible.

Clostridium difficile associated disease (CDAD) has shown a sustained increase worldwide over the last ten years. However, there are few studies on this topic in Latin America. We conducted a comprehensive literature review using medical databases of Latin American countries. We found only seven recent papers in which clinical characteristics and risk factors were analyzed; some included outcome variables. Of these articles, only one was prospective, while the rest were either retrospective, cross-sectional or case-control studies. Most studies were done among hospitalized adult patients, even though patients 13+ years were also included in some reports. Only two recent clinical studies used cell culture to determine a cytopathic effect and the rest included immunoenzymatic assays. In general, all the studies we reviewed showed that the use of fluorquinolones, clindamycin, and cephalosporins were the antibiotics mostly associated with CDAD. Treatment schedules generally included metronidazol, although vancomycin was reported in one. Attributable mortality was lower than the mortality described in previous reports from hospitals in developed countries. Studies where this outcome was included did not surpass 4%, a significant difference from the findings from developed countries. In Latin America there are few studies that describe this clinical problem, they generally include small sample sizes and most are retrospective. There is a clear need to design and carry out prospective studies that will allow us to determine the true prevalence of this health problem

The First Case of Antibiotic-associated Colitis by Clostridium difficile PCR Ribotype 027 in Korea

Clostridium difficile (C. difficile) is a common causative agent of pseudomembranous colitis (PMC). C. difficile-associated diarrhea (CDAD) ranges from mild diarrhea to life threatening PMC. Recently, a highly virulent strain of C. difficile polymerase chain reaction ribotype 027 was found in North America, Europe, and Japan. A 52-yr-old woman with anti-tuberculosis medication and neurogenic bladder due to traffic accident experienced five episodes of C. difficile PMC after taking antibiotics for pneumonia along with septic shock and acute renal failure. She was readmitted to the intensive care unit and treated with oral vancomycin with refractory of oral metronidazole, inotropics and probiotics for over 60 days. C. difficile isolated both at the first and the last admission was identified as C. difficile ribotype 027 by ribotyping, toxinotyping, and tcdC gene sequencing, which turned out the same pathogen as the epidemic hypervirulent B1/NAP1 strain. This is the first case of C. difficile PCR ribotype 027 in Korea. After discharge, she was maintained on probiotics and rifaximin for 3 weeks. She had no relapse for 6 months.

Management of Antibiotics-Associated Diarrhea / 대한소화기학회지

Antibiotics-associated diarrhea (AAD) is defined as unexplained diarrhea that occurs with the administration of antibiotics. Approximately 20% AAD cases are due to Clostridium difficile. Over the last decade, the incidence of Clostridium difficile-associated disease (CDAD) has progressively increased, and now a significant clinical problem. Recent change in the epidemiology of CDAD and the emergence of an epidemic hypervilruent strain suggest the need for greater attention for infection control, early diagnosis, and more effective treatment modality. However, since most cases of CDAD are both iatrogenic and nosocomial, careful selection of antibiotics, combined with proper hand hygiene and precaution by medical staffs are required.

Clinical Characteristics and Changing Epidemiology of Clostridium difficile-Associated Disease (CDAD) / 대한소화기학회지

BACKGROUND/AIMS: The spectrum of Clostridium difficile-associated disease (CDAD) ranges from mild diarrhea to life-threatening colitis. Recent studies reported an increase in incidence and severity of CDAD and the presence of severe community-acquired CDAD (CA-CDAD). The aims of this study were to investigate the incidence of CA-CDAD and non-antibiotics-associated CDAD, and to compare the clinical characteristics between hospital-acquired (HA) and CA-CDAD. METHODS: The medical records of 86 patients who were diagnosed as CDAD in Hanyang University Guri Hospital between January 2005 and October 2007 were retrospectively reviewed. RESULTS: Of the 86 patients (mean age 64 years), 53 patients were women. The most frequently prescribed antibiotics were cephalosporins (67.4%), followed by aminoglycosides (38.4%) and quinolones (14%). Of the 86 patients, the average duration of treatment and recovery time of symptoms were 11.5 days and 4.6 days, respectively. Seven percent of patients experienced relapse treatment. The overall incidence rate of CA-CDAD and non-antibiotics-associated CDAD were 10.5% and 22.1%, respectively. CA-CDAD group had lower rate of antimicrobial exposure whilst showing higher rate of complications compared to HA-CDAD group. Three patients in the CA-CDAD progressed towards a severe complicated clinical course, including septic shock. CONCLUSIONS: The incidence rate of CA-CDAD and non-antibiotics-associated CDAD were 10.5% and 22.1%, respectively. CA-CDAD tends to have a higher complication rate compared to HA-CDAD. Community clinicians needs to maintain a high level of suspicion for CDAD, whilst coping with the ever evolving epidemiologic change.

A Case of Pseudomenbranous Colitis after Paclitaxel and Carboplatin Chemotherapy / 대한소화기학회지

Antibiotics-associated pseudomembranous colitis is well documented and caused by abnormal overgrowth of toxin producing Clostridium difficile colonizing the large bowel of patients undergoing antibiotic therapy. Administration of chemotherapeutic agents is frequently complicated by diarrhea and enterocolitis. However, pseudomembranous colitis related to chemotherapeutic agent usage is very rare. We experienced a 67 old-years male patient diagnosed of non-small cell lung carcinoma who complained of watery diarrhea and abdominal pain after treated with paclitaxel and carboplatin. Sigmoidoscopic examination revealed diffusely scattered, whitish to yellowish pseudo-membrane with background edematous hyperemic mucosa from sigmoid colon to rectum. Histopathologic findings were consistent with pseudomembranous colitis as typical volcano-like exudate. The symptoms improved after stopping chemotherapy and treatment with metronidazole. In patients with persistent diarrhea and abdominal pain after receiving chemotherapy agents, although rare, pseudomembranous colitis should be considered as a differential diagnosis.